- Location
2
results for "
T1D
"-
an Extension of Jdrf-Bd Cooperation in Type 1 Diabetes Mellitus
Jun 24, 2013JDRF and Becton, Dickinson and Company (BD) are accelerating the development of new products that combine BD's insulin infusion and glucose sensing technologies through a new three-year collaboration. This commitment is an extension of ...
-
FDA Granted Orphan Drug Designation for Andromeda Biotech's DiaPep277 to T1D Patients
Dec 7, 2012The FDA has granted orphan drug designation for Andromeda Biotech's DiaPep277 to treat type 1 diabetes (T1D) patients with residual beta cell function. The orphan drug status offers seven years marketing exclusivity from the time of ...
Tags: DiaPep277, type 1 diabetes, T1D, residual beta cell
